Cure My Disease
Don't miss your cure!
Clinical trials sponsored by Shanghai Changzheng Hospital, explained in plain language.
This early-stage trial is testing the safety and initial effectiveness of combining two antibody drugs for men with metastatic castration-resistant prostate cancer (mCRPC). The study involves a very small group of 7 participants to see if the drug combination is safe and if it ca…
Phase: EARLY_PHASE1 • Sponsor: Shanghai Changzheng Hospital • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC